Trial Profile
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Sepantronium bromide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms LUCY
- Sponsors Astellas Pharma
- 04 Jun 2009 New trial record.